Tim Seymour Sees High Times Ahead For Cannabis Stocks By Benzinga
Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Tim Seymour Sees High Times Ahead For Cannabis Stocks

Published 28/03/2024, 15:09
Updated 28/03/2024, 16:10
© Reuters.  Tim Seymour Sees High Times Ahead For Cannabis Stocks

Benzinga - by Erica Kollmann, Benzinga Staff Writer.

The slumbering cannabis sector has reawakened following Germany's partial legalization and possible rescheduling of marijuana in the United States. Tim Seymour, founder and CIO of Seymour Asset Management, joined Benzinga's PreMarket Prep Wednesday and discussed his views on these "exciting times” in cannabis.

What Happened: The regulatory changes announced by Germany last week were a significant catalyst for the recent rally in weed stocks. Germany's new laws will take effect on April 1 and remove cannabis from the country's Narcotics Act, where it was listed as a banned substance subject to specific criminal provisions.

"Germany has quietly moved ahead of the U.S. They may totally, federally legalize the adult market before we do, as well," Seymour said on the show.

Tim Seymour will be speaking at the Benzinga Cannabis Capital Conference in Hollywood, Florida, on April 16-17. Secure your tickets for the conference ASAP. Prices will increase very soon! You can get a 20% discount on tickets following this link right now.

The portfolio manager pointed to Tilray Brands, Inc. (NASDAQ:TLRY) as the major distributor in Europe best-positioned to benefit from the new German regulations. The company made key investments in Germany years ago, which may generate returns under the new cannabis regulatory system, according to Seymour.

Why It Matters: Cannabis investors view Germany's progressive legal changes as a step in the right direction for the industry, which is poised to benefit from increased sales and revenue growth. Many are hopeful the U.S. will take a similar path to federal rescheduling and possible decriminalization.

Related News: Canopy Growth CEO Says German Cannabis Market Has ‘Ability To Grow 10x’ Following Legalization

Seymour highlighted the increasing number of states that have legalized both medical and adult-use marijuana. He sees rescheduling in the U.S. as inevitable, and noted that the Biden Administration is running out of time before the next election.

"There's no question about what's happening, no question about where it's eventually going to go," Seymour said.

Vice President Kamala Harris recently pressured the Drug Enforcement Agency (DEA) to quickly reschedule marijuana during a roundtable discussion at the White House earlier this month.

"Marijuana is considered as dangerous as heroin and more dangerous than fentanyl which is absurd, not to mention patently unfair," Harris said during the roundtable conversation.

Seymour expects growth in the cannabis industry to be magnified by major improvements in efficiency and a steady stream of catalysts ahead.

"Investors that are here now are certainly going to be rewarded," Seymour said.

TLRY Price Action: According to Benzinga Pro, Tilray shares were up 0.92% at $2.50 at publication time.

Image: asdqwejkl from Pixabay

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.